GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Increased by Guggenheim Capital LLC

Guggenheim Capital LLC lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 132,499 shares of the company's stock after buying an additional 5,926 shares during the quarter. Guggenheim Capital LLC's holdings in GE HealthCare Technologies were worth $10,359,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in GEHC. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $25,000. Runnymede Capital Advisors Inc. acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $28,000. Bank of Jackson Hole Trust purchased a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $32,000. Flagship Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter worth $34,000. Finally, OFI Invest Asset Management acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of several research analyst reports. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $97.27.

GE HealthCare Technologies Stock Up 1.2 %

Shares of GE HealthCare Technologies stock traded up $0.72 during trading on Tuesday, reaching $61.20. The company had a trading volume of 635,370 shares, compared to its average volume of 3,187,349. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market cap of $28.02 billion, a price-to-earnings ratio of 14.12, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm's fifty day moving average is $78.76 and its 200-day moving average is $82.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.23%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.